{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:54:08Z","timestamp":1782626048152,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Florey Institute of Neuroscience and Mental Health"},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP1045619"],"award-info":[{"award-number":["APP1045619"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP628699"],"award-info":[{"award-number":["APP628699"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP1066144"],"award-info":[{"award-number":["APP1066144"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001061","name":"Rebecca Cooper Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001061","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000163","name":"ARC","doi-asserted-by":"publisher","award":["FT100100689"],"award-info":[{"award-number":["FT100100689"]}],"id":[{"id":"10.13039\/100000163","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jad.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T17:13:51Z","timestamp":1445793231000},"page":"241-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Lower [3H]LY341495 binding to mGlu2\/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia"],"prefix":"10.1016","volume":"190","author":[{"given":"Caitlin E","family":"McOmish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Pavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhara","family":"Udawela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Scarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2015.10.004_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pbb.2014.04.002","article-title":"Optogenetics to study the circuits of fear- and depression-like behaviors: a critical analysis","volume":"122","author":"Belzung","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2015.10.004_bib2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","article-title":"Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders","volume":"32","author":"Beneyto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2015.10.004_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neulet.2011.03.077","article-title":"Group II metabotropic glutamate receptors in the striatum of non-human primates: dysregulation following chronic cocaine self-administration","volume":"496","author":"Beveridge","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jad.2015.10.004_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00406-014-0573-x","article-title":"Retinal dysfunction of contrast processing in major depression also apparent in cortical activity","volume":"265","author":"Bubl","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2015.10.004_bib6","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1176\/appi.ajp.2008.07121845","article-title":"Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients","volume":"165","author":"Bullock","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0165-0173(99)00031-4","article-title":"Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia","volume":"31","author":"Bunney","year":"2000","journal-title":"Brain Res. Brain Res."},{"key":"10.1016\/j.jad.2015.10.004_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jad.2015.10.004_bib9","series-title":"Applied regression including computing and graphics","author":"Cook","year":"1999"},{"key":"10.1016\/j.jad.2015.10.004_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.biopsych.2006.12.005","article-title":"Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia","volume":"62","author":"Corti","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0074-7742(04)59019-0","article-title":"NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia","volume":"59","author":"Coyle","year":"2004","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jad.2015.10.004_bib12","article-title":"Changes in cortical N-methyl-d-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide","author":"Dean","year":"2015","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0028-3908(97)00067-1","article-title":"[3H]raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects","volume":"36","author":"Dean","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2015.10.004_bib14","series-title":"Using CNS Tissue in Psychiatric Research","first-page":"67","article-title":"The localisation and quantification of molecular changes in the human brain using in situ radioligand binding and autoradiography","author":"Dean","year":"1999"},{"key":"10.1016\/j.jad.2015.10.004_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-1781(97)00125-X","article-title":"Repeated antidepressant drug treatment, time of death and frequency of handling do not affect [3H]paroxetine binding in rat cortex","volume":"73","author":"Dean","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2015.10.004_bib16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1017\/S1461145713001648","article-title":"Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramine","volume":"17","author":"Dean","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2015.10.004_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1461145711001702","article-title":"mTOR activation is required for the antidepressant effects of mGluR(2)\/(3) blockade","volume":"15","author":"Dwyer","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2015.10.004_bib18","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1073\/pnas.0405077101","article-title":"Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia","volume":"101","author":"Egan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jad.2015.10.004_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00441-006-0266-5","article-title":"Metabotropic glutamate receptors","volume":"326","author":"Ferraguti","year":"2006","journal-title":"Cell. Tissue Res."},{"key":"10.1016\/j.jad.2015.10.004_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pnpbp.2009.11.018","article-title":"Elevated level of metabotropic glutamate receptor 2\/3 in the prefrontal cortex in major depression","volume":"34","author":"Feyissa","year":"2010","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.schres.2011.01.008","article-title":"Density of metabotropic glutamate receptors 2 and 3 (mGluR2\/3) in the dorsolateral prefrontal cortex does not differ with schizophrenia diagnosis but decreases with age","volume":"128","author":"Frank","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2015.10.004_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jad.2015.10.004_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/syn.20164","article-title":"Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia","volume":"57","author":"Gupta","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.jad.2015.10.004_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2010.09.034","article-title":"The subcallosal cingulate gyrus in the context of major depression","volume":"69","author":"Hamani","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.expneurol.2011.10.032","article-title":"Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics","volume":"233","author":"Heim","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jad.2015.10.004_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1176\/ajp.153.4.533","article-title":"Problem of diagnosis in postmortem brain studies of schizophrenia","volume":"153","author":"Hill","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0006-8993(93)90202-X","article-title":"NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides","volume":"616","author":"Holemans","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2015.10.004_bib28","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1152\/jn.00875.2004","article-title":"Activation of metabotropic glutamate 2\/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats","volume":"93","author":"Homayoun","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.jad.2015.10.004_bib29","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","article-title":"The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder","volume":"35","author":"Jernigan","year":"2011","journal-title":"Prog. \u0160euro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S1461145708008985","article-title":"Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression","volume":"12","author":"Karolewicz","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2015.10.004_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0169-328X(94)00219-5","article-title":"Tissue pH as an indicator of mRNA preservation in human post-mortem brain","volume":"28","author":"Kingsbury","year":"1995","journal-title":"Brain res. Mol. Brain Res."},{"key":"10.1016\/j.jad.2015.10.004_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(97)00191-3","article-title":"LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors","volume":"37","author":"Kingston","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2015.10.004_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbr.2009.03.004","article-title":"The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex","volume":"201","author":"Koenigs","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jad.2015.10.004_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jad.2015.10.004_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuroscience.2012.09.057","article-title":"Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression","volume":"251","author":"Licznerski","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.jad.2015.10.004_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1503\/jpn.130242","article-title":"Metabotropic glutamate receptor mGluR2\/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics","volume":"39","author":"Matosin","year":"2014","journal-title":"J. Psychiatry Neurosci. Jpn."},{"key":"10.1016\/j.jad.2015.10.004_bib38","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0028-3908(02)00057-6","article-title":"Imipramine treatment up-regulates the expression and function of mGlu2\/3 metabotropic glutamate receptors in the rat hippocampus","volume":"42","author":"Matrisciano","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2015.10.004_bib39","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/sj.npp.1300507","article-title":"Impoverished rearing environment alters metabotropic glutamate receptor expression and function in the prefrontal cortex","volume":"29","author":"Melendez","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2015.10.004_bib40","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jad.2015.10.004_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuropharm.2014.08.009","article-title":"Evaluation of 5-HT2A and mGlu2\/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment","volume":"86","author":"Muguruza","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2015.10.004_bib42","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1073\/pnas.1216100110","article-title":"L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors","volume":"110","author":"Nasca","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jad.2015.10.004_bib43","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0306-4522(96)00316-8","article-title":"Metabotropic glutamate receptors mGluR2 and mGluR5 are expressed in two non-overlapping populations of Golgi cells in the rat cerebellum","volume":"75","author":"Neki","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.jad.2015.10.004_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3940(95)12248-6","article-title":"Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody","volume":"202","author":"Neki","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jad.2015.10.004_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-0102(97)00120-X","article-title":"Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody","volume":"30","author":"Ohishi","year":"1998","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.jad.2015.10.004_bib46","unstructured":"Ouellet-Plamondon, C.a.G., Tony P., 2012. Glutamate and Psychiatry in 2012-Up, up and Away!, Psychiatric Times."},{"key":"10.1016\/j.jad.2015.10.004_bib47","first-page":"525","article-title":"Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity","volume":"59","author":"Palucha","year":"2007","journal-title":"Pharmacol. Rep.: Pr."},{"key":"10.1016\/j.jad.2015.10.004_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1034\/j.1600-0447.108.s418.6.x","article-title":"Modern diagnostic concepts of the affective disorders","author":"Parker","year":"2003","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.jad.2015.10.004_bib49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-010-1914-8","article-title":"Impact of metabotropic glutamate 2\/3 receptor stimulation on activated dopamine release and locomotion","volume":"211","author":"Pehrson","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2015.10.004_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cne.20538","volume":"487","author":"Richards","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jad.2015.10.004_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00048679809062709","article-title":"Confirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience","volume":"32","author":"Roberts","year":"1998","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib52","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1038\/tp.2013.3","article-title":"Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA","volume":"3","author":"Scarr","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2015.10.004_bib53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jad.2015.10.004_bib54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/1566524033479663","article-title":"Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder","volume":"3","author":"Selemon","year":"2003","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jad.2015.10.004_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2015.10.004_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/(SICI)1098-2396(199803)28:3<220::AID-SYN5>3.0.CO;2-C","article-title":"Regulation of striatal dopamine release by metabotropic glutamate receptors","volume":"28","author":"Verma","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.jad.2015.10.004_bib57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00213-007-0974-x","article-title":"The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2\/3 agonist, LY379268, in mouse models predictive of antipsychotic activity","volume":"196","author":"Woolley","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2015.10.004_bib58","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s002100000305","article-title":"Binding of [3H](2S,1\u2019S,2\u2019S)-2-(9-xanthylmethyl)-2-(2\u2019-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes","volume":"362","author":"Wright","year":"2000","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.jad.2015.10.004_bib59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(24)29402-7","article-title":"[3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain","volume":"298","author":"Wright","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jad.2015.10.004_bib60","unstructured":"Yi, Y., Xu, F.M., Xie, H.W., 2011. [Correlation between the liver meridian and the frontal lobe in depression by needling at taichong (LV3): a resting-state fMRI study]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi=Chinese journal of integrated traditional and Western medicine\/Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban 31, 1044\u20131050."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715305632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715305632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:02:40Z","timestamp":1748664160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715305632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":60,"alternative-id":["S0165032715305632"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2015.10.004","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower [3H]LY341495 binding to mGlu2\/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}